Skip to Main Content

Do drug makers have an obligation to warn consumers about possible risks in languages besides English?

This is a key question being raised by an interesting case in California, where an appeals court has just reinstated a lawsuit brought by four people who claim they have the right to sue GlaxoSmithKline (GSK) because they read and speak only Armenian. As a result, they argue they were not aware of the warnings issued about the Avandia diabetes pill until long after Glaxo did so, and a deadline for filing a lawsuit arguably expired.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • the suit should be against the pharmacy as they should be explaining and in california there are plenty of Armenian American pharmacists and pharmacy’s.. with a powerful grassroots advocacy base, they will make it standard to also include Armenian as a language on the instructions, such a proud people

  • “Words fail me….” OK, not completely – a UK company complies with US-FDA regulations but is sued by persons residing in the US who speak (nor read??) neither American or British English. Did they suffer injury, I would assume so – should the case proceed? ” In my opinion ….
    գործը փակված է ….’the case is closed’

  • This is why when you legally come to our country you are required to learn the language as part of the citizen approval. It help them to assimilate to the country they are trying to become citizens of. If they took time to assimilate they wouldn’t be needing to sue an American company. It seems they have a lawsuit to get rich in just about every category they can think of. The new American dream for ilegales is making millions suing Americans.

Comments are closed.